Showing results (121-130 of 400) with videos related to
Sort By:
Pageof 40
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Addition of radiotherapy to the primary tumour in oligometastatic NSCLC: A systematic review and meta-analysisFausto Petrelli, Antonio Ghidini, Mary Cabiddu, et al.Surgical Oncology|June 15, 2019
Risk of second primary tumors in GIST survivors: A systematic review and meta-analysisFausto Petrelli, Gianluca Tomasello, Sandro Barni, et al.Current Opinion in Obstetrics & Gynecology|February 24, 2006
Locally advanced breast cancerSandro Barni, Mario MandalàPlos One|July 28, 2018
Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studiesFausto Petrelli, Chiara Lazzari, Raffaele Ardito, et al.Critical Reviews in Oncology/Hematology|June 18, 2026
Anticancer Drug Dosing: Balancing Benefit and ToxicityFausto Petrelli, Andrea D'Alessio, Lorenzo DottoriniRecenti Progressi in Medicina|April 12, 2017
[Cetuximab in association with an oxaliplatin-based chemotherapy as first-line treatment of metastatic colorectal cancer.]Fausto Petrelli, Antonio Ghidini, Alberto ZaniboniMolecular and Clinical Oncology|September 3, 2021
Topotecan or other agents as second-line therapy for relapsed small-cell lung cancer: A meta-analysis of randomized studiesFausto Petrelli, Antonio Ghidini, Andrea LucianiTumori|October 22, 2021
Curative treatments for colon cancer during the COVID-19 pandemic eraFausto Petrelli, Roberto Labianca, Alberto ZaniboniJournal of Geriatric Oncology|September 11, 2023
Prognostic relevance of sidedness in older patients with colon cancer: A review and pooled analysis of 227,218 patientsFausto Petrelli, Lorenzo Dottorini, Andrea LucianiEuropean Journal of Cancer (Oxford, England : 1990)|September 28, 2023
10 years or less of extended adjuvant endocrine therapy for postmenopausal breast cancer patients: A systematic review and network meta-analysisFausto Petrelli, Matteo Cavallone, Lorenzo DottoriniPageof 40